scholarly journals Evidence for autoinhibitory regulation of the c-src gene product. A possible interaction between the src homology 2 domain and autophosphorylation site.

1993 ◽  
Vol 268 (2) ◽  
pp. 1132-1140
Author(s):  
Y. Fukami ◽  
K. Sato ◽  
K. Ikeda ◽  
K. Kamisango ◽  
K. Koizumi ◽  
...  
Blood ◽  
2005 ◽  
Vol 106 (3) ◽  
pp. 879-885 ◽  
Author(s):  
Kazuhiko Maeda ◽  
Yoshihiro Baba ◽  
Yoshinori Nagai ◽  
Kozo Miyazaki ◽  
Alexander Malykhin ◽  
...  

Abstract Animals lacking Src homology 2 domain-containing inositol 5-phosphatase (SHIP) display a reduction in lymphopoiesis and a corresponding enhancement of myelopoiesis. These effects are mediated at least in part by elevated levels of interleukin 6 (IL-6). Here, we show the lymphopoiesis block in SHIP–/– mice is due to suppression of the lymphoid lineage choice by uncommitted progenitors. The suppression can be reproduced in vitro with recombinant IL-6, and IL-6 acts directly on hematopoietic progenitors. The block is partially overcome in SHIP–/– IL-6–/– double-deficient animals. IL-6 does not suppress but actually enhances proliferation of lymphoid-committed progenitors, indicating the IL-6 target cells are hematopoietic stem cells or multipotent progenitors. The findings suggest a mechanism for the lymphopenia that accompanies proinflammatory diseases.


2021 ◽  
Vol 16 (3) ◽  
pp. S217-S218
Author(s):  
M. Ito ◽  
J. Codony-Servat ◽  
A. Giménez-Capitán ◽  
M. Serra-Mitjans ◽  
F. Pérez-Ochoa ◽  
...  

EBioMedicine ◽  
2019 ◽  
Vol 39 ◽  
pp. 207-214 ◽  
Author(s):  
Niki Karachaliou ◽  
Andres Felipe Cardona ◽  
Jillian Wilhelmina Paulina Bracht ◽  
Erika Aldeguer ◽  
Ana Drozdowskyj ◽  
...  

1997 ◽  
Vol 272 (13) ◽  
pp. 8490-8497 ◽  
Author(s):  
Peter W. Janes ◽  
Martin Lackmann ◽  
W. Bret Church ◽  
Georgina M. Sanderson ◽  
Robert L. Sutherland ◽  
...  

Blood ◽  
2009 ◽  
Vol 114 (7) ◽  
pp. 1374-1382 ◽  
Author(s):  
Stefan Costinean ◽  
Sukhinder K. Sandhu ◽  
Irene M. Pedersen ◽  
Esmerina Tili ◽  
Rossana Trotta ◽  
...  

AbstractWe showed that Eμ-MiR-155 transgenic mice develop acute lymphoblastic leukemia/high-grade lymphoma. Most of these leukemias start at approximately 9 months irrespective of the mouse strain. They are preceded by a polyclonal pre–B-cell proliferation, have variable clinical presentation, are transplantable, and develop oligo/monoclonal expansion. In this study, we show that in these transgenic mice the B-cell precursors have the highest MiR-155 transgene expression and are at the origin of the leukemias. We determine that Src homology 2 domain–containing inositol-5-phosphatase (SHIP) and CCAAT enhancer-binding protein β (C/EBPβ), 2 important regulators of the interleukin-6 signaling pathway, are direct targets of MiR-155 and become gradually more down-regulated in the leukemic than in the preleukemic mice. We hypothesize that miR-155, by down-modulating Ship and C/EBPβ, initiates a chain of events that leads to the accumulation of large pre-B cells and acute lymphoblastic leukemia/high-grade lymphoma.


Sign in / Sign up

Export Citation Format

Share Document